Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Ofatumumab demonstrates activity against rituximab‐sensitive and ‐resistant cell lines, lymphoma xenografts and primary tumour cells from patients with B‐cell lymphoma
PaperCitations, authors & open-access status
Ofatumumab demonstrates activity against rituximab‐sensitive and ‐resistant cell lines, lymphoma xenografts and primary tumour cells from patients with B‐cell lymphoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 72 citations, 2011 year and closed oa status.
72
Citations
2011
Year
closed
OA Status